secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2022-01-05T23:59:59+00:00
Accession:  0001493152-22-000383
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed agrees to acquire Kind Therapeutics USA for $20M; buys minority interests for $2M
--------------------------------------------------------------------------------

- Acquires 100% of Kind Therapeutics for $20M: $13.5M cash, $6.5M in 4-year 6% promissory notes.
- Also buys minority interests in two subsidiaries for $2M, gaining ~99.7% of Mari-MD and ~94.3% of Mia.
- Kind holds Maryland medical cannabis licenses for cultivation, production, and provisional dispensary.
- Closing subject to Maryland Medical Cannabis Commission approval; related litigation dismissed with prejudice.
- CEO Bob Fireman expects another transformational year; MariMed already manages Kind's operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000149315222000383/0001493152-22-000383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000149315222000383/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-000383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer